30th ADLM International CPOCT Symposium

DoubleTree Pittsburgh | October 14–16, 2026
  • Start Date
    Oct 14, 2026
  • End Date
    Oct 16, 2026
  • Location
    Pittsburgh, PA
  • Duration
    3 days
Image of Pittsburgh skyline

Building resilience through point-of-care innovations

DoubleTree Pittsburgh
October 14–16, 2026

Planning Committee

Anna Fuezery, PhD, DABBC, CPP (Chair)
Alberta Precision Laboratories
Edmonton, AB, Canada

Nicholas Larkey, PhD, DABCC, NRCC, CPP, FADLM
University of Virginia
Charlottesville, VA, USA

Jeanne Mumford, MLS (ASCP)
Johns Hopkins Hospital
Baltimore, MD, USA

Nam Tran, PhD, HCLD (ABB), CLS/MLS (ASCP)cm
University of Pittsburgh, School of Medicine
Pittsburgh, PA, USA

Wanvisa Treebuphachatsakul, PhD
Naresuan University
Muang, Phitsanulok, Thailand


Target audience

This symposium is designed to meet the needs of laboratory professionals overseeing and/or carrying out point-of-care testing, clinical laboratory physicians, supervisors, managers, regulatory personnel, and other laboratory professionals interested in advances in point-of-care testing.

Learning objectives

Learning objectives coming soon.

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments. Faculty disclosures of relevant financial relationship(s) will be provided in respective presentations and program materials.

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation that conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This educational activity will be submitted for ACCENT continuing education credit.